S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967680.90062.ca |
| _version_ | 1827332426049781760 |
|---|---|
| author | Nizar J Bahlis Katja Weisel Maria-Victoria Mateos Hartmut Goldschmidt Tom Martin Daniel Morillo Donna Reece Paula Rodríguez-Otero Manisha Bhutani Anita D’souza Albert Oriol Laura Rosiñol Dachs Bhagirathbhai Dholaria Kalpana Bakshi Lijuan Kang Lien Vandenberk Damiette Smit Ralph Wäsch Niels W.C.J. van de Donk Ajai Chari |
| author_facet | Nizar J Bahlis Katja Weisel Maria-Victoria Mateos Hartmut Goldschmidt Tom Martin Daniel Morillo Donna Reece Paula Rodríguez-Otero Manisha Bhutani Anita D’souza Albert Oriol Laura Rosiñol Dachs Bhagirathbhai Dholaria Kalpana Bakshi Lijuan Kang Lien Vandenberk Damiette Smit Ralph Wäsch Niels W.C.J. van de Donk Ajai Chari |
| author_sort | Nizar J Bahlis |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:58:45Z |
| format | Article |
| id | doaj.art-2bcd2dcc8c5c44adb5296cd4eb1544f2 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:58:45Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-2bcd2dcc8c5c44adb5296cd4eb1544f22024-03-03T03:25:45ZengWileyHemaSphere2572-92412023-08-017e90062ca10.1097/01.HS9.0000967680.90062.ca202308003-00094S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTSNizar J Bahlis0Katja Weisel1Maria-Victoria Mateos2Hartmut Goldschmidt3Tom Martin4Daniel Morillo5Donna Reece6Paula Rodríguez-Otero7Manisha Bhutani8Anita D’souza9Albert Oriol10Laura Rosiñol Dachs11Bhagirathbhai Dholaria12Kalpana Bakshi13Lijuan Kang14Lien Vandenberk15Damiette Smit16Ralph Wäsch17Niels W.C.J. van de Donk18Ajai Chari191 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada2 University Medical Center Hamburg-Eppendorf, Hamburg, Germany3 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain4 Medizinische Klinik V, Universitätsklinikum Heidelberg and Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany5 Helen Diller Family Comprehensive Cancer Center, San Francisco Medical Center, University of California, San Francisco, United States6 Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain7 Princess Margaret Cancer Centre, Toronto, Canada8 Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain9 Levine Cancer Institute/Atrium Health, Charlotte, United States10 Medical College of Wisconsin, Milwaukee, United States11 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain12 Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain13 Vanderbilt University Medical Center, Nashville, United States14 Janssen Research & Development, Spring House, United States14 Janssen Research & Development, Spring House, United States15 Janssen Research & Development, Antwerp, Belgium16 Janssen Biologics Europe, Leiden, The Netherlands17 Freiburg University Medical Center, Freiburg, Germany18 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands19 Mount Sinai School of Medicine, New York, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000967680.90062.ca |
| spellingShingle | Nizar J Bahlis Katja Weisel Maria-Victoria Mateos Hartmut Goldschmidt Tom Martin Daniel Morillo Donna Reece Paula Rodríguez-Otero Manisha Bhutani Anita D’souza Albert Oriol Laura Rosiñol Dachs Bhagirathbhai Dholaria Kalpana Bakshi Lijuan Kang Lien Vandenberk Damiette Smit Ralph Wäsch Niels W.C.J. van de Donk Ajai Chari S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS HemaSphere |
| title | S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS |
| title_full | S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS |
| title_fullStr | S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS |
| title_full_unstemmed | S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS |
| title_short | S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS |
| title_sort | s192 talquetamab tal daratumumab dara in patients pts with relapsed refractory multiple myeloma rrmm updated trimm 2 results |
| url | http://journals.lww.com/10.1097/01.HS9.0000967680.90062.ca |
| work_keys_str_mv | AT nizarjbahlis s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT katjaweisel s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT mariavictoriamateos s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT hartmutgoldschmidt s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT tommartin s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT danielmorillo s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT donnareece s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT paularodriguezotero s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT manishabhutani s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT anitadsouza s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT albertoriol s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT laurarosinoldachs s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT bhagirathbhaidholaria s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT kalpanabakshi s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT lijuankang s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT lienvandenberk s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT damiettesmit s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT ralphwasch s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT nielswcjvandedonk s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results AT ajaichari s192talquetamabtaldaratumumabdarainpatientsptswithrelapsedrefractorymultiplemyelomarrmmupdatedtrimm2results |